Risk of Serious Infections with Carfilzomib in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

被引：2
|
作者：
Ball, Somedeb [1 ]
Behera, Tapas Ranjan [2 ]
Wongsaengsak, Sariya [1 ]
Khandelwal, Nuvneet [1 ]
Chakraborty, Rajshekhar [3 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Internal Med, Boston, MA 02115 USA
[3] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-125464
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1841
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Risk of Renal Toxicities With Carfilzomib In Patients With Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Ball, Somedeb
    Behera, Tapas Ranjan
    Adhikari, Nimesh
    Anwer, Faiz
    Chakraborty, Rajshekhar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S332 - S332
  • [2] Risk of Renal Toxicities with Carfilzomib in Patients with Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Ball, Somedeb
    Anwer, Faiz
    Behera, Tapas Ranjan
    Chakraborty, Rajshekhar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E114 - E115
  • [3] Infection risk with carfilzomib in multiple myeloma: a systematic review and meta-analysis of randomised controlled trials
    Wongsaengsak, Sariya
    Kopel, Jonathan
    Behera, Tapas R.
    Chakraborty, Rajshekhar
    Ball, Somedeb
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (02) : E95 - E97
  • [4] Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials
    Somedeb Ball
    Tapas Ranjan Behera
    Faiz Anwer
    Rajshekhar Chakraborty
    Annals of Hematology, 2020, 99 : 1265 - 1271
  • [5] Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials
    Ball, Somedeb
    Behera, Tapas Ranjan
    Anwer, Faiz
    Chakraborty, Rajshekhar
    ANNALS OF HEMATOLOGY, 2020, 99 (06) : 1265 - 1271
  • [6] Heart Failure with Carfilzomib in Patients with Multiple Myeloma: A Meta-analysis of Randomized Controlled Trials
    Rahman, M. Rubayat
    Ball, Somedeb
    Paz, Pablo
    Elmassry, Mohamed
    Vutthikraivit, Wasawat
    Bandyopadhyay, Dhrubajyoti
    Lavie, Carl J.
    Fonarow, Gregg C.
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (05) : 610 - 612
  • [7] RISK OF HEART FAILURE WITH CARFILZOMIB IN PATIENTS WITH MULTIPLE MYELOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Paz, Pablo
    Vutthikraivit, Wasawat
    Mantilla, Barbara
    El Nawaa, Saif
    Wongsanegsak, Sally
    Elmassry, Mohamed
    Rahman, M. Rubayat
    Whisenant, Ty
    Ball, Somedeb
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 986 - 986
  • [8] Systematic review and meta-analysis of randomized controlled trials of erythropoietin in multiple myeloma.
    Soares, HP
    Kumar, A
    Silvestri, F
    Djulbegovic, B
    BLOOD, 2004, 104 (11) : 70A - 70A
  • [9] Lenalidomide Treatment for Multiple Myeloma: Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Yang, Bo
    Yu, Rui-li
    Chi, Xiao-hua
    Lu, Xue-chun
    PLOS ONE, 2013, 8 (05):
  • [10] Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
    Zeng, Zhiyong
    Lin, Junfang
    Chen, Junmin
    ANNALS OF HEMATOLOGY, 2013, 92 (07) : 935 - 943
12345